Sign in
BLSM Stock Price, Chart, Stats & News
BlossomHill Therapeutics, Inc.
Save
BlossomHill Therapeutics, Inc. (BLSM) does not currently pay a dividend.
560.68M
Market cap
–
Current P/E
–
Forward P/E
BLSM chart
About
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.
Similar securities
Based on sector and market capitalization
Report issue